AR015916A1 - Formas de dosificacion de solucion encapsulada de sertralina y procedimiento. - Google Patents

Formas de dosificacion de solucion encapsulada de sertralina y procedimiento.

Info

Publication number
AR015916A1
AR015916A1 ARP980103145A ARP980103145A AR015916A1 AR 015916 A1 AR015916 A1 AR 015916A1 AR P980103145 A ARP980103145 A AR P980103145A AR P980103145 A ARP980103145 A AR P980103145A AR 015916 A1 AR015916 A1 AR 015916A1
Authority
AR
Argentina
Prior art keywords
dosage forms
serraline
procedure
encapsulated solution
encapsulated
Prior art date
Application number
ARP980103145A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21971076&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR015916(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR015916A1 publication Critical patent/AR015916A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se proveen formas de dosificacion de sertralina encapsulada en un vehículo inmiscible en agua. Dichas formas de dosificacion reducen Tmax y/o los efectoscolaterales y/o la precipitacion de sertralina en ambientes de uso que contienen ion cloruro tales como el tracto gastrointestinal.
ARP980103145A 1997-07-01 1998-06-29 Formas de dosificacion de solucion encapsulada de sertralina y procedimiento. AR015916A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5140197P 1997-07-01 1997-07-01

Publications (1)

Publication Number Publication Date
AR015916A1 true AR015916A1 (es) 2001-05-30

Family

ID=21971076

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980103145A AR015916A1 (es) 1997-07-01 1998-06-29 Formas de dosificacion de solucion encapsulada de sertralina y procedimiento.

Country Status (40)

Country Link
EP (1) EP0980241B1 (es)
JP (1) JP3585245B2 (es)
KR (1) KR100371730B1 (es)
CN (1) CN1261792A (es)
AP (1) AP945A (es)
AR (1) AR015916A1 (es)
AT (1) ATE256457T1 (es)
AU (1) AU724635B2 (es)
BG (1) BG103917A (es)
BR (1) BR9809712A (es)
CA (1) CA2290973C (es)
CO (1) CO4940405A1 (es)
DE (1) DE69820608T2 (es)
DK (1) DK0980241T3 (es)
DZ (1) DZ2544A1 (es)
EA (1) EA001905B1 (es)
ES (1) ES2210760T3 (es)
GT (1) GT199800090A (es)
HR (1) HRP980378B1 (es)
HU (1) HUP0002250A3 (es)
ID (1) ID24673A (es)
IL (1) IL133075A0 (es)
IS (1) IS5266A (es)
MA (1) MA24586A1 (es)
MY (1) MY119728A (es)
NO (1) NO996492L (es)
NZ (1) NZ501252A (es)
OA (1) OA11246A (es)
PA (1) PA8454001A1 (es)
PE (1) PE97299A1 (es)
PL (1) PL337807A1 (es)
PT (1) PT980241E (es)
SK (1) SK282914B6 (es)
TN (1) TNSN98123A1 (es)
TR (1) TR199903282T2 (es)
TW (1) TW382597B (es)
UA (1) UA68350C2 (es)
UY (1) UY25070A1 (es)
WO (1) WO1999001113A1 (es)
ZA (1) ZA985709B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2001002119A0 (en) * 1998-10-13 2001-03-22 Pfizer Prod Inc Sertraline oral concentrate.
US6727283B2 (en) 1998-10-13 2004-04-27 Pfizer Inc. Sertraline oral concentrate
ES2256032T3 (es) 1999-09-03 2006-07-16 Apbi Holdings, Llc Utilizacion de dapoxetina, un inhibidor selectivo de la recaptacion de serotonina, para el tratamiento de una disfuncion sexual.
BR0113626A (pt) 2000-08-30 2003-06-17 Pfizer Prod Inc Formulações de liberação sustentada para secretores de hormÈnio do crescimento
EP1375659A1 (en) * 2002-06-18 2004-01-02 Laboratorio di Diagnostica Moleculare Soluble capsules containing stock mixtures for easy preparation of chemical or biological solutions
CN1728982A (zh) * 2002-10-31 2006-02-01 阿尔扎公司 可增加疏水性药物生物利用度的药物制剂
WO2016020936A2 (en) * 2014-07-21 2016-02-11 Patel Jayendrakumar Dasharathlal A novel oral gastroretentive pharmaceutical dosage form
CN108014087A (zh) * 2017-12-27 2018-05-11 江苏联环药业股份有限公司 一种盐酸舍曲林胶囊的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0782445T3 (da) * 1994-09-19 2002-05-06 Bristol Myers Squibb Pharma Co Kombination af en opioidantagonist og en selektiv serotoningenoptagelsesinhibitor til behandling af alkoholisme og alkoholafhængighed
EP0768083B1 (en) * 1995-07-17 2003-03-26 Pfizer Inc. Sertraline for treating post myocardial infarction patients

Also Published As

Publication number Publication date
AP945A (en) 2001-02-28
ID24673A (id) 2000-07-27
DE69820608T2 (de) 2004-12-23
PT980241E (pt) 2004-03-31
UA68350C2 (en) 2004-08-16
JP2000512316A (ja) 2000-09-19
CN1261792A (zh) 2000-08-02
PE97299A1 (es) 1999-10-13
GT199800090A (es) 1999-12-21
MY119728A (en) 2005-07-29
NZ501252A (en) 2004-11-26
HUP0002250A2 (hu) 2000-12-28
PL337807A1 (en) 2000-09-11
OA11246A (en) 2002-11-19
DE69820608D1 (de) 2004-01-29
NO996492L (no) 2000-02-29
TR199903282T2 (xx) 2000-08-21
TNSN98123A1 (fr) 2005-03-15
MA24586A1 (fr) 1998-12-31
ZA985709B (en) 2000-01-10
HUP0002250A3 (en) 2001-01-29
EP0980241A1 (en) 2000-02-23
KR20010013588A (ko) 2001-02-26
CO4940405A1 (es) 2000-07-24
CA2290973C (en) 2003-06-17
HRP980378B1 (en) 2001-12-31
JP3585245B2 (ja) 2004-11-04
EA199900963A1 (ru) 2000-08-28
SK282914B6 (sk) 2003-01-09
PA8454001A1 (es) 2000-05-24
CA2290973A1 (en) 1999-01-14
DK0980241T3 (da) 2004-04-05
TW382597B (en) 2000-02-21
BR9809712A (pt) 2000-07-11
WO1999001113A1 (en) 1999-01-14
EP0980241B1 (en) 2003-12-17
UY25070A1 (es) 2000-12-29
DZ2544A1 (fr) 2003-02-08
AP9801279A0 (en) 1998-06-30
KR100371730B1 (ko) 2003-02-07
HRP980378A2 (en) 1999-04-30
NO996492D0 (no) 1999-12-27
ATE256457T1 (de) 2004-01-15
IL133075A0 (en) 2001-03-19
IS5266A (is) 1999-11-23
AU724635B2 (en) 2000-09-28
SK180599A3 (en) 2001-01-18
AU7545098A (en) 1999-01-25
BG103917A (bg) 2000-07-31
ES2210760T3 (es) 2004-07-01
EA001905B1 (ru) 2001-10-22

Similar Documents

Publication Publication Date Title
ID20142A (id) Laminasi komposisi kopolimer acak propilena/1-butena dan film komposit yang memakai komposisi tersebut
ID20188A (id) Pelapisan ko-ekstruksi yang paling tidak terdiri dari satu lapisan kopolimer cabang propilena
ID23439A (id) Turunan-turunan 3-piperidil-4-oksokuinazolin dan komposisi-komposisi farmasi yang sama
ID27530A (id) Turunan-turunan imidazo piridin yang menghambat keluarnya asam lambung
ID25543A (id) Alpha-aril-n-alkinitron dan komposisi farmasi yang mengandungnya
PT971702E (pt) Microgranulos contendo cis-platina
AR015916A1 (es) Formas de dosificacion de solucion encapsulada de sertralina y procedimiento.
BR9406108A (pt) Abrigo de emergencia
DE69408423D1 (de) Turbinegehäuse mit Dichtungskörper
ECSP982574A (es) Formas de dosificacion de solucion encapsulada de sertralina
ES2191756T3 (es) Composiciones acuosas de primera capa para usar en aplicaciones de primera capa/capa transparente.
ID17972A (id) Film buram dengan dasar polipropilena yang lebih baik
KR980002883U (ko) 증류수 및 초순수 제조장치
KR970009919U (ko) 발광효과를 갖는 텐트
ES1030234Y (es) Receptaculo expositor probatorio, para percibir y probar el olor de cualquier liquido/s que se encuentra/n en su interior, a traves de salida/s tipo roll-on.
BR9201741A (pt) Bola flutuante
KR940025939U (ko) 수영모자
KR950006605U (ko) 텐트용 컨넥터 연결 구조
ITMI951435A0 (it) Attrezzatura di navigazione complementare al corpo umano con funzione alternativa al nuoto
KR940018836U (ko) 크레파스포장용 케이스
KR970054159U (ko) 특수 구조장비를 구비한 자동차
KR950006606U (ko) 텐트
KR970025939U (ko) 접지판의 접촉면적을 넓게 하기 위한 구조
SE9500397D0 (sv) Emergency utilities autonomus Centre & Shelters emutacs
FI1295U1 (fi) En baerande traekonstruktion

Legal Events

Date Code Title Description
FC Refusal